Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytochrome P-450 CYP2D6 | 4 | 2026 | 20 | 0.710 |
Why?
|
| Coumarins | 1 | 2019 | 45 | 0.560 |
Why?
|
| Analgesics, Opioid | 3 | 2026 | 252 | 0.540 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 92 | 0.530 |
Why?
|
| Hypertension | 4 | 2026 | 835 | 0.490 |
Why?
|
| Genetic Testing | 3 | 2026 | 91 | 0.440 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2026 | 193 | 0.340 |
Why?
|
| Colitis, Ulcerative | 2 | 2022 | 70 | 0.330 |
Why?
|
| Antidepressive Agents | 2 | 2026 | 65 | 0.290 |
Why?
|
| Depression | 2 | 2026 | 863 | 0.270 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 495 | 0.220 |
Why?
|
| Multicenter Studies as Topic | 4 | 2024 | 61 | 0.200 |
Why?
|
| Genomics | 2 | 2022 | 293 | 0.190 |
Why?
|
| Humans | 20 | 2026 | 43102 | 0.190 |
Why?
|
| Intestinal Mucosa | 2 | 2022 | 134 | 0.180 |
Why?
|
| Benchmarking | 1 | 2021 | 32 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2024 | 375 | 0.180 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 42 | 0.180 |
Why?
|
| Colitis | 1 | 2022 | 71 | 0.170 |
Why?
|
| Genome | 1 | 2022 | 149 | 0.170 |
Why?
|
| Perioperative Care | 1 | 2020 | 11 | 0.170 |
Why?
|
| Paneth Cells | 1 | 2020 | 3 | 0.170 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2020 | 9 | 0.170 |
Why?
|
| Intraoperative Complications | 1 | 2020 | 20 | 0.170 |
Why?
|
| Muramidase | 1 | 2020 | 30 | 0.160 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 104 | 0.160 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 49 | 0.160 |
Why?
|
| Blood Pressure | 4 | 2026 | 666 | 0.150 |
Why?
|
| Cannabinoids | 1 | 2020 | 73 | 0.150 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2020 | 126 | 0.150 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2019 | 24 | 0.150 |
Why?
|
| Mice, Knockout | 2 | 2020 | 1035 | 0.150 |
Why?
|
| HT29 Cells | 1 | 2019 | 60 | 0.150 |
Why?
|
| Caco-2 Cells | 1 | 2019 | 64 | 0.150 |
Why?
|
| Postoperative Complications | 1 | 2020 | 263 | 0.140 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2019 | 49 | 0.140 |
Why?
|
| Adult | 9 | 2026 | 13872 | 0.140 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 423 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2024 | 1600 | 0.140 |
Why?
|
| Genetic Variation | 1 | 2020 | 430 | 0.130 |
Why?
|
| Female | 11 | 2026 | 24698 | 0.130 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 133 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 1869 | 0.130 |
Why?
|
| Antihypertensive Agents | 3 | 2026 | 287 | 0.130 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 449 | 0.120 |
Why?
|
| Middle Aged | 7 | 2026 | 12222 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2019 | 434 | 0.120 |
Why?
|
| Male | 9 | 2026 | 23409 | 0.110 |
Why?
|
| Codeine | 2 | 2026 | 4 | 0.110 |
Why?
|
| Tramadol | 2 | 2026 | 3 | 0.110 |
Why?
|
| Hydrocodone | 2 | 2026 | 4 | 0.110 |
Why?
|
| Macrophages | 1 | 2019 | 529 | 0.110 |
Why?
|
| Mice | 3 | 2022 | 6644 | 0.100 |
Why?
|
| Pharmacogenetics | 2 | 2026 | 67 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1070 | 0.100 |
Why?
|
| Genotype | 2 | 2026 | 800 | 0.100 |
Why?
|
| Aged | 5 | 2026 | 8214 | 0.100 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1455 | 0.090 |
Why?
|
| Obesity | 1 | 2020 | 1151 | 0.090 |
Why?
|
| Animals | 3 | 2022 | 16992 | 0.070 |
Why?
|
| Neoplasms | 1 | 2019 | 1377 | 0.070 |
Why?
|
| Pain Measurement | 1 | 2024 | 183 | 0.050 |
Why?
|
| Seasons | 1 | 2023 | 139 | 0.050 |
Why?
|
| Genetic Counseling | 1 | 2022 | 15 | 0.050 |
Why?
|
| Dextran Sulfate | 1 | 2022 | 19 | 0.050 |
Why?
|
| Disclosure | 1 | 2022 | 39 | 0.040 |
Why?
|
| Population Groups | 1 | 2022 | 59 | 0.040 |
Why?
|
| Temperature | 1 | 2023 | 313 | 0.040 |
Why?
|
| Laboratories | 1 | 2021 | 40 | 0.040 |
Why?
|
| Colon | 1 | 2022 | 120 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2020 | 34 | 0.040 |
Why?
|
| Consensus | 1 | 2020 | 48 | 0.040 |
Why?
|
| STAT6 Transcription Factor | 1 | 2020 | 17 | 0.040 |
Why?
|
| Goblet Cells | 1 | 2020 | 12 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2022 | 174 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 245 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2020 | 71 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 780 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2020 | 144 | 0.040 |
Why?
|
| Cannabis | 1 | 2020 | 90 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 694 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 734 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 368 | 0.030 |
Why?
|
| Base Sequence | 1 | 2019 | 983 | 0.030 |
Why?
|
| Mass Screening | 1 | 2021 | 541 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 934 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2020 | 925 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 758 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 307 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 1596 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 1759 | 0.030 |
Why?
|
| United States | 1 | 2026 | 5205 | 0.030 |
Why?
|
| Young Adult | 1 | 2026 | 5080 | 0.030 |
Why?
|
| Adolescent | 1 | 2026 | 6081 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2019 | 1271 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3156 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 2853 | 0.020 |
Why?
|